The new year has offered investors a more diverse and mature cannabis market as leaders in the space solidify positions in international markets and newcomers find ways to differentiate strategies in the industry.

With the first quarter of 2019 now over, the Investing News Network has rounded up the top marijuana stocks for the January to March period. All figures were collected at the close of markets on March 29.

The stocks listed below have market caps between C$10 million and C$500 million, except for the stocks on the Toronto Stock Exchange (TSX) which, given the exchange’s size, have market caps between C$1 billion and C$15 billion.

The CSE’s top cannabis stocks

1. Heritage Cannabis Holdings (CSE:CANN,OTC Pink:HERTF)

Heritage is a vertically integrated cannabis firm with various subsidiaries in different sub-sectors such as extraction and growing.

In February, the company completed the integration of BriteLife Sciences into its holdings, which will allow it to expand further in the medical cannabis market.

The company has received a boost in visibility since it was added to the Horizons Marijuana Life Sciences ETF (TSX:HMMJ).

Investors showed an interest for Heritage’s continued path in the market with an increase in share value of 288.24 percent for the first quarter of 2019.

2. Ventura Cannabis and Wellness (VCAN) (CSE:VCAN,OTC Pink:CVHIF)

Formerly known as BLVD Centers, VCAN operates addiction treatment centers across the US. Now, it is transitioning to a marijuana-focused strategy.

The company is pairing its original plan with new acquisitions in the cannabis space, such as dispensaries in Cathedral City, California, and Portland, Oregon.

VCAN captured the attention of the market and received a boost to its share value of 127.27 percent during the first quarter of 2019.

3. Sproutly Canada (CSE:SPR,OTCQB:SRUTF)

Sproutly’s work focuses on developing water soluble cannabis options for the upcoming edible and infused product launch in Canada.

While the company plans to launch its future products under specific brands, in March the firm confirmed the debut of CALIBER, a recreational premium cannabis brand marketing smokable products, from its subsidiary, Toronto Herbal Remedies.

Sproutly’s promise attracted investors during the quarter, with a 123.08 percent increase in value.

The TSXV’s top cannabis stocks

1. Khiron Life Sciences (TSXV:KHRN,OTCQB:KHRNF)

Khiron is a unique cannabis play in the Canadian public markets. The company operates in Colombia and pursues other business activities in the Latin American market.

Last quarter was a busy one for Khiron, as it introduced new branded products and secured entries into markets like Chile and Uruguay through separate agreements.

Khiron’s shares rose 150.32 percent to make it the top gainer on the TSXV.

2. 48North (TSXV:NRTH)

48North is focused on putting forward novel cannabis products that stand out and on bringing its brands to the Canadian market.

As part of the launch for its F8 brand, the company signed a supply agreement with Canopy Growth-owned (NYSE:CGC,TSX:WEED) retailer Tokyo Smoke and the Ontario Cannabis Store.

Like Heritage on the Canadian Securities Exchange (CSE), 48North was also added to the Horizons Marijuana Life Sciences ETF.

48North continued a steady pace that led to a 127.87 percent increase to its share price for the first quarter of 2019.

3. Harvest One Cannabis (TSXV:HVT,OTCQX:HRVOF)

Harvest One holds a portfolio of cannabis assets and works on the development of products for the health and wellness sector.

During the quarter, Harvest One upgraded its OTC Market Group listing to the OTCQX Best Market exchange.

As part of its Q2 2019 financial update to shareholders, the company announced that its subsidiary Satipharm had officially launched the sales of reformulated cannabidiol capsules online in Europe.

Thanks to its performance this past quarter, Harvest One attracted the eyes of investors, increasing in value by 120.93 percent.

The TSX’s top cannabis stocks

1. The Green Organic Dutchman (TGOD) (TSX:TGOD,OTCQX:TGODF)

TGOD is an organic marijuana licensed producer (LP) in Canada with a global focus for its products.

In February, the firm secured its first supply agreement with a Canadian province thanks to a deal with Ontario, meaning its products can be sold to Ontario consumers.

As part of its 2018 year end results, the company reported C$263.5 million in cash and restricted cash for the expansion of its facilities and expansion in international markets.

TGOD has secured the biggest returns so far in 2019 with a rise in value of 80.52 percent.

2. Aurora Cannabis (TSX:ACB,NYSE:ACB)

One of the leading Canadian LPs of cannabis took in a solid quarter of growth. In particular, the company continued its expansion plans on a global scale, notably in the European medical market.

The producer announced revenues of C$54.2 million during its Q2 2019 period, driven mostly by the opening of the adult use market in Canada.

A strong quarter boosted Aurora shares with a 70.52 percent increase.

3. HEXO (TSX:HEXO,NYSEAMERICAN:HEXO)

HEXO finally completed a coveted listing on a US exchange when it reached the NYSE American exchange on January 23.

During the quarter, the team at HEXO also moved ahead with an acquisition plan for fellow marijuana producer Newstrike Brands (TSXV:HIP,OTC Pink:NWKRF).

HEXO was able to attract the attention of the market and secured a rise in value for the quarter of 69.48 percent.


INNdepth

Want more details? Check out these articles for more INNdepth coverage.

Want an overview of investing in cannabis stocks? Check Investing in the Cannabis Industry


Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Heritage Cannabis Holdings, Harvest One Cannabis and Khiron Life Sciences are clients of the Investing News Network. This article is not paid-for content.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less